Cardinal Health, Inc.
CAH
Positions held
Your positionsCAH isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-07.
- Cardinal Health operates in the essential medical distribution industry, which benefits from ongoing healthcare demand and an aging population.
- Revenue increased by 4% compared to the prior quarter, reaching $63.7 billion.
- The company has a strong earnings growth rate of 68.8%, indicating robust financial performance.
- The company's negative price-to-book ratio of -18.87 raises concerns about its asset valuation.
- Operating margin decreased to 1.28% in the latest quarter from 1.38% in the previous quarter.
- The current ratio is 0.883, suggesting potential liquidity issues.
Fundamentals
| Market cap | $55.33B | Enterprise value | $60.88B | Trailing P/E | 33.05 | Forward P/E | 17.00 |
| PEG | 1.16 | Price / book | -19.31 | Beta | 0.50 | Dividend yield | 0.86% |
| Revenue growth | 5.8% | Earnings growth | 68.8% | Gross margin | 3.8% | Operating margin | 1.3% |
| Profit margin | 0.7% | ROE | — | ROA | 3.7% | Debt / equity | — |
| Current ratio | 0.88 | Free cash flow | $4.75B | Analyst recommendation | buy | Mean target | $270.33 |
| 52w high | $258.30 | 52w low | $151.87 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $63.7B | $60.9B | $65.6B | $64.0B | $60.2B | — |
| Op margin | 1.3% | 1.4% | 1.2% | 1.2% | 1.0% | — |
| Net income | $398M | $399M | $467M | $450M | $239M | — |
| Gross margin | 4.0% | 4.1% | 3.7% | 3.6% | 3.7% | — |
| Gross profit | $2.6B | $2.5B | $2.4B | $2.3B | $2.2B | — |
| Operating income | $814M | $842M | $763M | $754M | $585M | — |
- Revenue +4% vs prior quarter ($63.7B vs $60.9B).
- Gross margin 4% (was 4.1% prior quarter).
Yearly (6y)
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $254.2B | $222.6B | $226.8B | $205.0B | — |
| Op margin | 1.2% | 1.0% | 0.9% | 0.9% | — |
| Net income | $1.7B | $1.6B | $852M | $330M | — |
| Gross margin | 3.8% | 3.7% | 3.3% | 3.4% | — |
| Gross profit | $9.8B | $8.2B | $7.4B | $6.9B | — |
| Operating income | $3.2B | $2.3B | $2.1B | $1.8B | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · What Does CVS Health (CVS) Gain From Extending Its Drug Distribution Deals To 2032?
2026-10-06 · Reasons to Retain Cardinal Health Stock in Your Portfolio for Now
2026-10-06 · Eli Lilly and vs. Novo Nordisk A/S: Which Healthcare Stock Is a Better Buy in 2026?
2026-10-06 · CVS' Health Care Benefits Arm Shows Better Core Trends: What's Ahead?
2026-10-06 · 1 Healthcare Stock with Exciting Potential and 2 We Find Risky
2026-10-05 · Cardinal Health (CAH) Outperforms Broader Market: What You Need to Know
2026-10-05 · Disposable Medical Device Market to Reach USD 144.85 Billion by 2030, Growing at a CAGR of 4.9% – MarketsandMarkets™
2026-10-05 · How Extending CVS Distribution Through 2032 At Cardinal Health (CAH) Has Changed Its Investment Story
2026-10-04 · Amgen vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026?
2026-10-02 · Zacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDex
2026-10-01 · AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?
2026-10-01 · Cardinal Health rises on extended CVS distribution deal
Price (daily)
Full chart · RSI · MACD · patterns